Contract research organization Chiltern announced today that it is expanding its Japanese and Asian presence through its purchase of Integrated Development Associates.
Financial terms of the deal were not disclosed.
IDA has staff in Japan, Korea and Southeast Asia – and offers opportunities to integrate the region into global drug development, according to Chiltern. IDA’s expertise includes establishing regulatory and development pathways in Japan, and implementing clinical trials across Asia.
Get the full story on our sister site, Medical Design & Outsourcing.
